Atea Pharmaceuticals Competitors and Similar CompaniesClear all
Atea Pharmaceuticals's competitors and similar companies include Chrysalis BioTherapeutics, Selva Therapeutics, Adagio Therapeutics and Ipsen.
 Atea Pharmaceuticals Atea Pharmaceuticals is a biopharmaceutical company specializing in oral direct-acting antiviral therapies. |  Chrysalis BioTherapeutics ChrysalisBioTherapeutics is a biopharmaceutical company developing regenerative drugs. |  Selva Therapeutics Selva Therapeutics is a biotechnology company dedicated to the development of therapeutics for infectious diseases. |  Adagio Therapeutics Adagio is a clinical-stage biopharmaceutical company focusing on the discovery and development of antibody-based solutions for infectious diseases with pandemic potential. | ||
Founding Date | Founding Date 2014 | Founding Date 2012 | Founding Date N/A | Founding Date 2020 | Founding Date 1929 |
Type | Type Public | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Boston, US HQ Boston, US | Locations Galveston, US HQ | Locations San Diego, US HQ | Locations Waltham, US HQ | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more |
Employees | Employees 552% decrease | Employees 6 | Employees 4 | Employees 74 | Employees 5,358 |
Valuation ($) | Valuation ($) 290.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 516.2 m | Valuation ($) 10.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $53.4m (FY, 2025) | Revenue (est.) €3.7b (FY, 2025) |
Net income | Net income ($158.3m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($52.5m) (FY, 2025) | Net income €445.1m (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 10.4m (over 5 years ago) | Latest funding round $ 3m (almost 6 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 11m | Total funding raised $ 3m | Total funding raised $ 466m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Chrysalis BioTherapeutics
HQ
Galveston, US
Employees
6
ChrysalisBioTherapeutics is a biopharmaceutical company developing regenerative drugs.
View companySelva Therapeutics
HQ
San Diego, US
Employees
4
Selva Therapeutics is a biotechnology company dedicated to the development of therapeutics for infectious diseases.
View companyAdagio Therapeutics
HQ
Waltham, US
Employees
74
Adagio is a clinical-stage biopharmaceutical company focusing on the discovery and development of antibody-based solutions for infectious diseases with pandemic potential.
View company